Drug Type Synthetic peptide |
Synonyms BENEDO |
Target |
Action agonists |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Australia (06 Mar 2025), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus, Type 2 | Australia | 06 Mar 2025 | |
Obesity | Australia | 06 Mar 2025 | |
Overweight | Australia | 06 Mar 2025 |